Fingerprint
Dive into the research topics of 'Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer
Joel B. Nelson, William Love, Joseph L. Chin, Fred Saad, Claude C. Schulman, Darryl J. Sleep, Jiang Qian, Joyce Steinberg, Michael Carducci
Research output: Contribution to journal › Article › peer-review
223
Scopus
citations